PB1805: INSIGHTS FROM ORAL AZACITIDINE EARLY ACCESS PROGRAM IN FRANCE: PATIENT POPULATION WITH ACUTE MYELOID LEUKEMIA RECEIVING ORAL-AZA FOR MAINTENANCE OF COMPLETE REMISSION AFTER...

por Raffoux, E., De Botton, S., Ades, L., Carré, M., Cluzeau, T., Saillard, C., Heiblig, M., Beckerich, F., Gastaud, L., Dupuis, A., Richez, U., Dumas, P.-Y.
Publicado 2022